Hershey's Kisses Celebrates 35 Years of Iconic 'Holiday Bells' Commercial on NBC's "Christmas in Rockefeller" Special — Neutral
HSY PRNewsWire — November 25, 2025The beloved sound of Hershey's Kisses' 'Holiday Bells' comes to New York City with an immersive experience this holiday season HERSHEY, Pa. , Nov. 25, 2025 /PRNewswire/ -- Hershey's Kisses brand joins as a Premier Sponsor of NBC's annual live Holiday special, "Christmas in Rockefeller Center" for the first time.
France: TotalEnergies Demobilizes Its Floating LNG Terminal in Le Havre — Neutral
TTE Business Wire — November 25, 2025PARIS--(BUSINESS WIRE)--In 2022, when Europe faced a major energy crisis due to a sharp decline in gas imports from Russia, France had to increase its imports of liquefied natural gas (LNG) to ensure its own energy security and contribute to that of Europe. To this end, and at the request of the authorities, TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) provided France, at its own expense and without any public subsidies, with a LNG floating storage and regasification unit (FSRU) in the port o.
DAL's Largest Transatlantic Schedule in 2026: Growth Story Hotting up? — Positive
DAL Zacks Investment Research — November 25, 2025Delta plans its largest transatlantic schedule for summer 2026, adding new routes and upgraded amenities to tap rebounding travel demand.
Petrobras to Delay Drilling Contracts Due to Global Oil Surplus — Neutral
PBR Zacks Investment Research — November 25, 2025PBR reportedly delays key Buzios' drilling contracts to 2026 as it navigates a shifting oil market and pushes for more cost-efficient offshore growth.
Dell Technologies (DELL) reports earnings after Tuesday's close. Rick Ducat pinpoints several technical developments occurring on its chart and draws upon previous chart patterns to show near-term areas to watch into the report.
Centene's Recovery Still Has Legs - Further Margin Expansion Ahead — Positive
CNC Seeking Alpha — November 25, 2025CNC remains a Great Buy, thanks to its promising multi-year margin recovery prospects arising from the drastically raised premiums by the mid 30%s. While the management already expects to see "some degree of membership attrition," I am of the opinion that this is an inevitable (and temporary) pain for its future margin recovery. The raised FY2025 guidance and the bottoming in its FQ3'25 HBR imply the worst may be behind us, with FY2026 likely to bring forth improved numbers.
INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit with the Schall Law Firm — Neutral
INSP GlobeNewsWire — November 25, 2025LOS ANGELES, Nov. 25, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inspire Medical Systems, Inc. (“Inspire” or “the Company”) (NYSE: INSP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before January 5, 2026.
AbbVie and adMare BioInnovations Foster Life Sciences Innovation with the Launch of the AbbVie Biotech Innovators Award in Quebec — Neutral
ABBV GlobeNewsWire — November 25, 2025MONTREAL, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Today, AbbVie (NYSE: ABBV), jointly with the adMare BioInnovations, announced the launch of the AbbVie Biotech Innovators Award, a prize to help foster innovation and support growth in Quebec's life sciences sector.
Can-Am Unveils the Industry's Most Affordable HVAC-Equipped Side-by-Sides and a New Camouflage Outlander Electric — Neutral
DOOO PRNewsWire — November 25, 2025VALCOURT, QC , Nov. 25, 2025 /PRNewswire/ - Can-Am, iconic brand of BRP Inc. (TSX:DOO) (NASDAQ:DOOO), today announced a new package of the iconic Defender and a new color for the groundbreaking Outlander Electric. Starting at $23,999 USD*, the new Defender DPS CAB HD10 with HVAC, available in three-seat and MAX (six-seat) configurations, is now the most affordable HVAC-equipped side-by-side in the industry, delivering premium comfort and rugged capability at an unmatched value.
Kinetic Surpasses Major Milestone in Broken Arrow: 25,000 Fiber Homes Passed — Neutral
UNIT GlobeNewsWire — November 25, 2025TULSA, Okla., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Kinetic, a leading provider of residential and business internet, today announced that it has passed 25,000 homes with high-speed multi-gigabit fiber internet in the greater Broken Arrow area. And officials say there's no slowing in construction planned anytime soon.
Meta reportedly in talks to buy AI chips from Google, Best Buy earnings beat Wall Street estimates — Positive
BBY GOOG GOOGL META Yahoo Finance — November 25, 2025Meta reportedly in talks to buy AI chips from Google, Best Buy earnings beat Wall Street expectations Morning Brief: Market Sunrise anchor Ramzan Karmali breaks down the latest market news for November 25, 2025. According to a report in The Information, Meta is reportedly in talks to spend billions on purchasing Google AI chips.
Historic Iron Dome Funding Boost Creates New Opportunities for Rimon Technologies, Reinforcing Strategic Value of Nukkleus' Pending Acquisition — Neutral
NUKK GlobeNewsWire — November 25, 2025Expanded Iron Dome funding drives long-term demand for Rimon's core technology Expanded Iron Dome funding drives long-term demand for Rimon's core technology
Performance Shipping Inc. Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2025 — Neutral
PSHG GlobeNewsWire — November 25, 2025ATHENS, Greece, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Performance Shipping Inc. (NASDAQ: PSHG) (“we” or the “Company”), a global shipping company specializing in the ownership of tanker vessels, today reported net income of $3.9 million for the third quarter of 2025. This result is compared to a net income of $12.4 million for the same period in 2024. Earnings per share, basic and diluted, for the third quarter of 2025 were $0.28 and $0.10, respectively.
Best Buy lifts annual forecast after quarterly results top estimates — Positive
BBY Proactive Investors — November 25, 2025Best Buy Co Inc (NYSE:BBY) raised its full-year forecast on Tuesday after stronger demand for new consumer electronics helped the retailer post quarterly revenue and profit ahead of Wall Street expectations. The company reported non-GAAP earnings of $1.40 per share, beating estimates by $0.09, while revenue rose 2.3% from a year earlier to $9.67 billion, surpassing analysts' forecasts by about $80 million.
Boston Scientific's Margins Strengthen in Q3: What's Driving It? — Positive
BSX Zacks Investment Research — November 25, 2025BSX posts stronger Q3 margins as growth in EP and WATCHMAN lifts product mix despite tariff pressure.
NRG vs. NEE: Which Utility Stock Is the Smarter Investment for Now? — Positive
NEE NRG Zacks Investment Research — November 25, 2025NRG's surging earnings estimates, high ROE and strong price gains sharpen its edge in a shifting clean-energy utilities market compared with NEE.
Dick's Sporting Goods (DKS) Q3 Earnings Surpass Estimates — Positive
DKS Zacks Investment Research — November 25, 2025Dick's Sporting Goods (DKS) came out with quarterly earnings of $2.78 per share, beating the Zacks Consensus Estimate of $2.62 per share. This compares to earnings of $2.75 per share a year ago.
Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence — Neutral
ALUR Business Wire — November 25, 2025NATICK, Mass.--(BUSINESS WIRE)---- $ALUR--Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced initial results on the combination of the Allurion Program with low-dose tirzepatide therapy to optimize muscle mass and GLP-1 adherence. 76 patients treated with the Allurion Smart Capsule were started on low-dose tirzepatide after completing their first 45 days of balloon therapy. The starting dose of tirzepatide was 2.5mg and.
Tiziana Life Sciences' Phase 2 foralumab trial joins Healey ALS MyMatch Program — Positive
TLSA Proactive Investors — November 25, 2025Tiziana Life Sciences Ltd (NASDAQ:TLSA) announced that its Phase 2 clinical trial evaluating intranasal foralumab in patients with amyotrophic lateral sclerosis (ALS) has been accepted into the ALS MyMatch Program at the Sean M Healey & AMG Center for ALS at Mass General Brigham. The study, supported by a grant from the ALS Association, will be led by Principal Investigators Suma Babu and James Berry at Mass General Brigham.
Visa: The Cash Machine Trading At A Historical Discount — Positive
V Seeking Alpha — November 25, 2025V is rated a Buy, supported by its asset-light model, exceptional profitability, and strong cash flow generation. V's resilient consumer spending, innovation in stablecoins, and robust shareholder returns reinforce its long-term investment appeal. Despite high valuation multiples, V trades at a 17% discount to its 5-year average P/E, offering a compelling risk-reward profile.